U.S. Patent & Trademark Office Awards Patent for Predictive

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
U.S. Patent & Trademark Office Awards Patent for Predictive Alert Targeting Invention to AtHoc

SAN MATEO, Calif., Oct. 3, 2013 (GLOBE NEWSWIRE) -- AtHoc, Inc ., today announced the issuance of U.S. Patent No. 8542117 for predictive alert targeting, another innovation from the global leader in network-centric interactive crisis communications.

Predictive alert targeting elevates the effectiveness of the AtHoc Interactive Warning System (AtHoc IWS) with improved accuracy and faster delivery of critical information, leading to expedited resolution. All emergency personnel and response teams know that when a crisis occurs, shaving off seconds when responding to any incident saves lives.

"We continue to innovate to meet the growing needs of our customers," said Aviv Siegel, CTO of AtHoc. "The predictive alert targeting technology uses data based on end users' favored contact devices (smartphones, desktop PCs, IP phones, etc.) and previous contact results to give emergency managers awareness of optimal ways to target their message, which increases alert message reach when seconds count."

Predictive alert targeting can be applied, for example, to a work environment which may have a higher proportion of its population using desktops and mobile devices as the preferred alerting channels. With predictive alert targeting, emergency managers can tailor the selection of devices for maximum reach, further safeguarding all workforce personnel.

"This innovation increases the certainty of reaching someone with an alert message," continued Siegel, "which contrasts sharply with the traditional 'push and pray' approach when organizations only find out about the performance of their notification system by reviewing reports well after an incident. We are very excited to bring this invention to our customer base."

About AtHoc
AtHoc is the pioneer and recognized leader in providing network-centric interactive crisis communication systems to military, homeland security, government, healthcare, industrial and commercial organizations. AtHoc's products are used for physical security, force protection, personnel accountability, recall and regulatory compliance. Millions of end-users worldwide, in organizations such as the U.S. Department of Veterans Affairs, Baylor Health, Scott & White Health System, Raymond W. Bliss Army Medical Center, UCLA, U.S. Department of Defense and the U.S. Department of Homeland Security rely on AtHoc's unified notification systems for their emergency alerting and critical communication needs. AtHoc was recently awarded Government Security News' (GSN) 2012 Homeland Security Award for Best Mass Notification System  and has also been recognized by Gartner, Inc. as a leader in its  Magic Quadrant for Emergency Mass Notification Services and by IHS Inc. as The Fastest Growing Mass Notification Software Supplier . For more information about AtHoc, please visit http://www.athoc.com .

Deb Montner Montner & Associates 203-226-9290 dmontner AT montner.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 37

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Growth of Middle-Class Investors through Mutual Fund Ownership

Updated Category News Views 149

Mutual Funds and the Rise of the Middle-Class Investor Over recent years, mutual fund ownership has surged among middle-class families. According to insights from the Investment Company Institute (ICI), this trend signifies a vital transition as middle-income households increasingly seek investment opportunities. The growing presence of mutual funds in the American...

Continue Reading
Rques Exchange Reinforces Its Brand with Compliance Strategy

Updated Category News Views 180

Rques Exchange Reinforces Brand with Regulatory Frameworks Rques Exchange is taking significant steps to enhance its brand by emphasizing its commitment to regulatory alignment, operational transparency, and governance integrity in various markets. With global authorities increasingly scrutinizing digital asset platforms, Rques aims to position itself as a technology...

Continue Reading
Business Growth and Confidence: Provident Bank's Insights

Updated Category News Views 120

Increasing Business Confidence for the Future Recently, Provident Bank, a prominent financial institution based in New Jersey, conducted an enlightening Economic Outlook survey. This survey reflects the sentiments of 1,000 business leaders regarding the 2025 economic prospects. The results showcase a robust sense of optimism and confidence among businesses as they look...

Continue Reading
Performance Food Group Co: A Five-Year Stock Journey

Updated Category News Views 219

Unlocking the Value of Investment in Performance Food Group Co Performance Food Group Co (NYSE: PFGC) has delivered impressive returns over the last five years, standing out in the competitive market landscape. With an annualized return that has surpassed the market by 9.42%, investors have seen an average growth rate of around 24.5%. This stock is not just another entry...

Continue Reading
Understanding Rathbones Group Plc's Disclosure Requirements

Updated Category News Views 227

Key Information on Disclosure Requirements Understanding how companies disclose their shareholding is crucial for investors and stakeholders alike. Rathbones Group Plc plays an essential role in managing these disclosures, particularly regarding relevant securities that represent substantial interests in listed companies. Full Name of the Discloser The full name of the...

Continue Reading